Wnt/β-Catenin Signaling as a Driver of Hepatocellular Carcinoma Progression: An Emphasis on Molecular Pathways
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Liver cancers cause a high rate of death worldwide and hepatocellular carcinoma (HCC) is considered as the most common primary liver cancer. HCC remains a challenging disease to treat. Wnt/β-catenin signaling pathway is considered a tumor-promoting factor in various cancers; hence, the present review focused on the role of Wnt signaling in HCC, and its association with progression and therapy response based on pre-clinical and clinical evidence. The nuclear translocation of β-catenin enhances expression level of genes such as c-Myc and MMPs in increasing cancer progression. The mutation of CTNNB1 gene encoding β-catenin and its overexpression can lead to HCC progression. β-catenin signaling enhances cancer stem cell features of HCC and promotes their growth rate. Furthermore, β-catenin prevents apoptosis in HCC cells and increases their migration via triggering EMT and upregulating MMP levels. It is suggested that β-catenin signaling participates in mediating drug resistance and immuno-resistance in HCC. Upstream mediators including ncRNAs can regulate β-catenin signaling in HCC. Anti-cancer agents inhibit β-catenin signaling and mediate its proteasomal degradation in HCC therapy. Furthermore, clinical studies have revealed the role of β-catenin and its gene mutation ( CTNBB1 ) in HCC progression. Based on these subjects, future experiments can focus on developing novel therapeutics targeting Wnt/β-catenin signaling in HCC therapy. Keywords: liver cancer, drug resistance, immunotherapy, Wnt signaling, non-coding RNAs
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783 · cited 1×
“were first identified in acute myeloid leukemia and it was found that they can increase number of colony-formation capacitors.(87) CSCs are responsible for developing heterogenous feature of tumors and is in contrast with conventional belief that tumor heterogeneity is mediated by genetic and epigenetic alterations.”
BackgroundA decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871 · cited 1×
“CSCs are responsible for developing heterogenous feature of tumors and is in contrast with conventional belief that tumor heterogeneity is mediated by genetic and epigenetic alterations.(88,89) CSCs have been isolated from various tumors including glioma, lung cancer, breast cancer, and liver cancer.”
BackgroundSanger, H. L., Klotz, G., Riesner, D., Gross, H. J., & Kleinschmidt, A. K. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.11.3852 · Cited by 2,296 · cited 1×
“CircRNAs CircRNAs are another category of ncRNAs that were first recognized in plant studies.(221) CircRNAs have low expression in cells and they were first believed to be a result of RNA splicing.”
BackgroundLong Noncoding RNAs with Enhancer-like Function in Human Cells
Ørom, U. A., Derrien, T., Beringer, M., Gumireddy, K., Gardini, A., Bussotti, G., Lai, F., Zytnicki, M., Notredame, C., Huang, Q., et al. (2010) · Cell · doi:10.1016/j.cell.2010.09.001 · Cited by 1,721 · cited 1×
“Interaction of lncRNAs with DNA or transcriptional factors mediates lncRNA function at transcriptional level.(203,204) At post-transcriptional level, lncRNAs interact with proteins or mRNA.”
BackgroundRuiz de Galarreta, M., Bresnahan, E., Molina-Sánchez, P., Lindblad, K. E., Maier, B., Sia, D., Puigvehi, M., Miguela, V., Casanova-Acebes, M., Dhainaut, M., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0074 · Cited by 912 · cited 1×
“In mediating immune evasion feature of HCC cells, β-catenin signaling impairs recruitment of dendritic cells and decreases activity of T cells.(157) These studies highlight the role of β-catenin signaling in triggering immune evasion in HCC cells and subsequent strategies should focus on suppressing β-catenin expressi…”
BackgroundHarding, J. J., Nandakumar, S., Armenia, J., Khalil, D. N., Albano, M., Ly, M., Shia, J., Hechtman, J. F., Kundra, R., El Dika, I., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2293 · Cited by 602 · cited 1×
“The mutation in CTNNB1 and abnormal activation of Wnt/β-catenin signaling reduce response of HCC patients to immune checkpoint inhibitors.(78) Hence, two conclusions can be made, first, βcatenin mutation should be highlighted based on region and race; second, most of the experiments demonstrated oncogenic role of β-ca…”
BackgroundThe multifaceted role of reactive oxygen species in tumorigenesis
Kirtonia, A., Sethi, G., & Garg, M. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03536-5 · Cited by 452 · cited 1×
“It is obvious that enhanced ROS generation can reduce viability of HCC cells via mediating apoptosis.(99,100) A recent experiment has shed more light on the role of ROS in HCC.”
BackgroundSelf-citationLi, B., Cao, Y., Meng, G., Qian, L., Xu, T., Yan, C., Luo, O., Wang, S., Wei, J., Ding, Y., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2018.11.063 · Cited by 245 · cited 1×
“In this way, GLS1 reduces ROS levels to induce Wnt signaling and mediate nuclear translocation of β-catenin which favors HCC stemness.(101) As mentioned in the introduction section, GSK-3β is a negative regulator of Wnt signaling and inhibits its activation via mediating proteasomal degradation of β-catenin.”
BackgroundFan, Q., Yang, L., Zhang, X., Ma, Y., Li, Y., Dong, L., Zong, Z., Hua, X., Su, D., Li, H., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0673-y · Cited by 216 · cited 1×
“In this way, autophagy stimulates β-catenin signaling to increase expression level of monocarboxylate transporter 1 (MCT1), resulting in glycolysis-mediated HCC growth.(131) In this case, autophagy plays a tumorpromoting role and its inhibition impairs growth of HCC cells.”
BackgroundWnt‐induced transcriptional activation is exclusively mediated by TCF/LEF
Schuijers, J., Mokry, M., Hatzis, P., Cuppen, E., & Clevers, H. (2014) · The EMBO Journal · doi:10.1002/embj.201385358 · Cited by 191
Burke, Z., & Oliver, G. (2002) · Mechanisms of Development · doi:10.1016/s0925-4773(02)00240-x · Cited by 177
p53 mutation as a source of aberrant β-catenin accumulation in cancer cells
Cagatay, T., & Ozturk, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205919 · Cited by 110
Liu, Y., Zhang, J.-B., Qin, Y., Wang, W., Wei, L., Teng, Y., Guo, L., Zhang, B., Lin, Z., Liu, J., et al. (2013) · Hepatology · doi:10.1002/hep.26398 · Cited by 105 · cited 1×
“The overexpression of PROX1 leads to enhanced migration and invasion of HCC cells via hypoxia inducible factor-1α (HIF-1α) upregulation.(164) Notably, PROX1 can be involved in mediating sorafenib resistance of HCC cells.”
BackgroundLiu, Y., Ye, X., Zhang, J.-B., Ouyang, H., Shen, Z., Wu, Y., Wang, W., Wu, J., Tao, S., Yang, X., et al. (2015) · Oncogene · doi:10.1038/onc.2015.7 · Cited by 93
Hale, G., Liu, X., Hu, J., Xu, Z., Che, L., Solomon, D., Tsokos, C., Shafizadeh, N., Chen, X., Gill, R., et al. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.122 · Cited by 73 · cited 1×
“As exon 3 β-catenin mutation is common in HCC and enhances its progression, glutamine synthase staining can be utilized for its detection.(72) Another experiment has”
BackgroundJin, X., Gong, L., Peng, Y., Li, L., & Liu, G. (2021) · Aging · doi:10.18632/aging.202137 · Cited by 24 · cited 1×
“One of the challenges in HCC therapy is the emergence of CP resistance, and overexpression of Nrf2 and HIF-1α can lead to this condition.(237) The inhibition of PI3K/Akt axis by miRNA-27a-3p results in enhanced CP cytotoxicity against HCC cells.”
Background
Cited by
Tumor cell plasticity in targeted therapy-induced resistance: Mechanisms and new strategies
Shi, Z.-D., Pang, K., Wu, Z.-X., Dong, Y., Hao, L., Qin, J.-X., Wang, W., Chen, Z.-S., & Han, C.-H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01383-x · Cited by 256
Mirzaei, S., Saghari, S., Bassiri, F., Raesi, R., Zarrabi, A., Hushmandi, K., Sethi, G., & Tergaonkar, V. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30759 · Cited by 243
Self-citationKim, N. Y., Jung, Y. Y., Yang, M. H., Chinnathambi, A., Govindasamy, C., Narula, A. S., Namjoshi, O. A., Blough, B. E., & Ahn, K. S. (2022) · Biochimie · doi:10.1016/j.biochi.2022.05.018 · Cited by 24
Metadata
- Authors
- Deldar Abad Paskeh, M., Mirzaei, S., Ashrafizadeh, M., Zarrabi, A., & Sethi, G.
- Venue
- Journal of Hepatocellular Carcinoma
- Publisher
- Informa UK Limited
- Published
- 2021-11
- Volume
- Volume 8
- Pages
- 1415-1444
- ISSN
- 2253-5969 (ISSN-L)
- OpenAlex
- W3217289739
- Cited by
- 135
- References
- 17
- FWCI
- 6.37
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.